Related Experiment Video
Updated: Aug 7, 2026

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
Published on: September 7, 2013
Effects of mechlorethamine (HN2, nitrogen mustard) on UV-induced carcinogenesis in hairless mouse skin
Abstract:
The influence of mechlorethamine (HN2, nitrogen mustard) on UV-induced carcinogenesis was examined in the hairless mouse skin in vivo. Noncarcinogenic amounts of topically applied HN2 and carcinogenic levels of UVB energy were used in the study. The HN2 applications significantly accelerated the appearance and growth of cutaneous tumors in this study. Thus HN2 acted as either a promoter or cocarcinogen for UV-induced cancer formation. Although the mechanism of this effect was not established, combinations of UVB radiation and HN2 topical therapy pointed to an increased incidence of cutaneous tumors in human skin.
Insights
Mechlorethamine (HN2, nitrogen mustard) accelerated UV-induced skin tumors in mice, acting as a promoter or cocarcinogen. This suggests topical HN2 combined with UVB may increase human skin cancer risk.
Area of Science:
- Dermatology
- Oncology
- Toxicology
Background:
- UVB radiation is a known cause of skin cancer.
- Mechlorethamine (HN2, nitrogen mustard) is a chemotherapeutic agent.
- The combined effects of HN2 and UVB on skin carcinogenesis are not fully understood.
Purpose of the Study:
- To investigate the influence of mechlorethamine (HN2) on UV-induced carcinogenesis in a hairless mouse model.
- To determine if HN2 acts as a promoter or cocarcinogen in UV-induced skin cancer.
Main Methods:
- Hairless mice were exposed to carcinogenic levels of UVB radiation.
- Noncarcinogenic amounts of mechlorethamine (HN2) were applied topically.
- Tumor development and growth were monitored.
Main Results:
- Topical HN2 significantly accelerated the appearance and growth of cutaneous tumors.
- HN2 demonstrated a promoting or cocarcinogenic effect in UV-induced carcinogenesis.
- The study established a link between UVB exposure and HN2 topical therapy.
Conclusions:
- Mechlorethamine (HN2) acts as a promoter or cocarcinogen in UV-induced skin cancer.
- Combinations of UVB radiation and topical HN2 therapy may increase the incidence of cutaneous tumors in human skin.
- Further research is needed to elucidate the underlying mechanisms.
More Related Videos
Related Concept Videos
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Mutagenicity and Carcinogenicity

![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)